Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Michele Monteil"'
Autor:
Lesley Roberts, Carla-Maria Alexander, Michele Monteil, Madhura Manjunath, Emile Mohammed, Valerie Wilson, Stefan Wilson
Publikováno v:
Vaccine: X, Vol 18, Iss , Pp 100487- (2024)
This study compares the humoral immune response of a cohort of renal transplant recipients (RTRs), in Trinidad & Tobago following two-dose primary immunization with non-mRNA vaccines amidst the COVID-19 pandemic. RTRs along with healthy, age-and gend
Externí odkaz:
https://doaj.org/article/63a543325cdb496b8cfa1a22d935ca83
Autor:
Melissa B Davis, Andrea Walens, Rupali Hire, Kauthar Mumin, Andrea M Brown, DeJuana Ford, Elizabeth W Howerth, Michele Monteil
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0140098 (2015)
The Atypical ChemoKine Receptor 1 (ACKR1) gene, better known as Duffy Antigen Receptor for Chemokines (DARC or Duffy), is responsible for the Duffy Blood Group and plays a major role in regulating the circulating homeostatic levels of pro-inflammator
Externí odkaz:
https://doaj.org/article/47b077fa40b741998d3210f66c3e6fda
Publikováno v:
Childhood Obesity. 16:204-210
Background: Obesity in children continues to be a global epidemic. Given the recent focus on the potential role gut microbiota play in the development of obesity and the continuous rise of obesity ...
Autor:
I'nasia Brown, Haythem Ali, Lisa A. Newman, Mary Egan, Elizabeth W. Howerth, Jamie Hodgson, S. David Nathanson, Brittany D. Jenkins, Rupali Hire, Rachel Martini, Andrea Brown, Melissa Davis, Petros Nikolinakos, Rick A. Kittles, Briana Bennett, Clayton Yates, Dhananjay Chitale, Michele Monteil
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 28:690-700
Background: Tumor-specific immune response is an important aspect of disease prognosis and ultimately impacts treatment decisions for innovative immunotherapies. The atypical chemokine receptor 1 (ACKR1 or DARC) gene plays a pivotal role in immune re
Autor:
Elizabeth A. Howerth, Petros Nikolinakos, Haythem Ali, Melissa Davis, Michele Monteil, Clayton Yates, Brittany D. Jenkins, Lisa A. Newman, Rachel A. Martini
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 29:IA27-IA27
Disparities in breast cancer survival among ethnic groups have been a persistent finding over the past five decades, exacerbated in part by the lack of improvement to non-white patient outcomes, despite treatment advancements that have improved clini
Autor:
Brittany D, Jenkins, Rachel N, Martini, Rupali, Hire, Andrea, Brown, Briana, Bennett, I'nasia, Brown, Elizabeth W, Howerth, Mary, Egan, Jamie, Hodgson, Clayton, Yates, Rick, Kittles, Dhananjay, Chitale, Haythem, Ali, David, Nathanson, Petros, Nikolinakos, Lisa, Newman, Michele, Monteil, Melissa B, Davis
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 28(4)
Tumor-specific immune response is an important aspect of disease prognosis and ultimately impacts treatment decisions for innovative immunotherapies. The Atypical Chemokine Receptor 1 (ACKR1/DARC) gene, plays a pivotal role in immune regulation and h
Autor:
Brianna Bennett, Michele Monteil, Rupali Hire, Michael Lou, Melissa Davis, Elizabeth W. Howerth, Hailey Campbell, Andrea Walens, Kauthar Mumin
Publikováno v:
Cancer Research. 75:P1-07
Duffy Antigen Receptor for chemokines (DARC) is known to regulate the biological activities of chemokines. It has been implicated in the progression of various diseases including different types of cancer, affecting survival, proliferation and metast
Autor:
Brittany D. Jenkins, Rachel Martini, Kevin Gardner, Michele Monteil, Dorrah Deeb, Lisa Newman, Melissa Davis
Publikováno v:
Cancer Research. 79:4565-4565
Breast cancer (BC) is a heterogeneous disease that leads to varied molecular subtypes and distinct clinical outcomes. Tumor heterogeneity, which is in part influenced by genetic ancestry, contributes to racial disparities in BC. This disparity has pe
Autor:
Elizabeth W. Howerth, Michele Monteil, Rupali Hire, Melissa Davis, Brittany D. Jenkins, Rachel Martini
Publikováno v:
Cancer Research. 77:953-953
Interactions between chemokines and their receptors can improve a host’s anti-tumor response by influencing the targeted migration of immune cells via a chemokine gradient. Atypical Chemokine Receptor 1 (ACKR1/DARC), a genetically diverse transmemb
Publikováno v:
Cancer Research. 77:P6-01
The breast tumor microenvironment is a complex assortment of cancer and host immune cells that interact to produce a myriad of clinical outcomes for breast cancer (BrCa) patients.Chemokine receptors, such asthe Atypical Chemokine Receptor 1 (ACKR1),